Expert Interview
Discussing P0942 Orismilast for the treatment of moderate to severe Ulcerative Colitis and the analysis of preliminary data from UCORIS, a phase 2a, open-label, single-arm exploratory clinical trial.
Ticker(s): ABBVInstitution: Mayo Clinic
- Senior Associate Consultant in the Section of Gastroenterology and Hepatology and Professor of Medicine at the Mayo Clinic (Previously Director, Inflammatory Bowel Disease Center at Boston Medical Center).
- Manages several hundred unique patients with Crohn's disease.
- Familiar with GALAXI and GRAVITI studies on Tremfya.
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
